X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3234) 3234
Publication (327) 327
Book Chapter (35) 35
Book Review (26) 26
Book / eBook (3) 3
Conference Proceeding (3) 3
Dissertation (3) 3
Data Set (1) 1
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2371) 2371
index medicus (2128) 2128
transplantation (1767) 1767
solid-organ transplantation (1593) 1593
male (1281) 1281
female (1222) 1222
middle aged (997) 997
adult (958) 958
surgery (824) 824
immunology (779) 779
recipients (749) 749
risk factors (651) 651
solid organ transplantation (627) 627
organ transplant recipients (577) 577
infectious diseases (562) 562
health aspects (553) 553
transplantation of organs, tissues, etc (542) 542
kidney transplantation (532) 532
aged (517) 517
immunosuppression (510) 510
infection (453) 453
disease (451) 451
retrospective studies (440) 440
adolescent (427) 427
transplants & implants (420) 420
immunosuppressive agents - therapeutic use (395) 395
treatment outcome (393) 393
risk-factors (389) 389
solid organ transplant (388) 388
child (383) 383
kidneys (373) 373
renal-transplantation (363) 363
cytomegalovirus (357) 357
kidney transplantation - adverse effects (345) 345
organ transplantation - adverse effects (341) 341
liver (333) 333
liver transplantation (320) 320
kidney-transplantation (302) 302
young adult (299) 299
organ transplantation (289) 289
pediatrics (289) 289
analysis (278) 278
immunosuppressive agents - adverse effects (276) 276
liver-transplantation (271) 271
lung transplantation (262) 262
tacrolimus (259) 259
mortality (256) 256
incidence (250) 250
immunotherapy (242) 242
pharmacology & pharmacy (238) 238
antiviral agents - therapeutic use (237) 237
children (237) 237
immunocompromised host (231) 231
infections (230) 230
child, preschool (227) 227
transplant recipients (225) 225
time factors (223) 223
risk (220) 220
solid-organ (219) 219
liver transplantation - adverse effects (217) 217
prophylaxis (213) 213
epstein-barr-virus (212) 212
management (209) 209
follow-up studies (208) 208
therapy (207) 207
heart (197) 197
prevention (197) 197
diagnosis (196) 196
graft rejection - prevention & control (196) 196
prospective studies (191) 191
microbiology (190) 190
virus diseases (185) 185
cytomegalovirus infections (183) 183
research (180) 180
urology & nephrology (180) 180
graft rejection (174) 174
solid-organ transplant (174) 174
epidemiology (168) 168
prognosis (168) 168
animals (167) 167
survival (167) 167
medical research (166) 166
care and treatment (163) 163
cytomegalovirus infections - prevention & control (163) 163
article (159) 159
heart transplantation (159) 159
infant (158) 158
graft survival (156) 156
patients (155) 155
outcomes (154) 154
viral load (153) 153
graft rejection - immunology (151) 151
immunosuppressive agents (151) 151
medicine & public health (151) 151
cancer (146) 146
medicine, experimental (145) 145
stem-cell transplantation (145) 145
immunosuppressive agents - administration & dosage (144) 144
kidney (144) 144
ganciclovir (142) 142
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3178) 3178
Spanish (55) 55
French (22) 22
German (9) 9
Korean (3) 3
Japanese (2) 2
Turkish (2) 2
Dutch (1) 1
Estonian (1) 1
Portuguese (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Transplantation, ISSN 0041-1337, 02/2018, Volume 102, Issue 2S Suppl 1, pp. S60 - S70
ABSTRACTMalignancy is the second most common single cause of death observed in organ transplant recipients. The excess cancer risk is related to intensity and... 
SOLID-ORGAN TRANSPLANTATION | SURGERY | RENAL-ALLOGRAFT RECIPIENTS | IMMUNOLOGY | TRANSPLANTATION | PHASE-II TRIAL | TUBEROUS SCLEROSIS COMPLEX | NONMELANOMA SKIN-CANCER | KAPOSIS-SARCOMA | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS | KIDNEY-TRANSPLANTATION | SQUAMOUS-CELL CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | TOR Serine-Threonine Kinases - metabolism | Tumor Virus Infections - virology | Humans | Immunosuppressive Agents - therapeutic use | Neoplasms - prevention & control | Protein Kinase Inhibitors - adverse effects | TOR Serine-Threonine Kinases - antagonists & inhibitors | Neoplasms - virology | Time Factors | Graft Rejection - mortality | Tumor Virus Infections - immunology | Anticarcinogenic Agents - adverse effects | Opportunistic Infections - immunology | Drug Therapy, Combination | Anticarcinogenic Agents - therapeutic use | Organ Transplantation - mortality | Graft Rejection - enzymology | Opportunistic Infections - virology | Graft Rejection - prevention & control | Risk Factors | Neoplasms - mortality | Treatment Outcome | Calcineurin Inhibitors - adverse effects | Animals | Signal Transduction - drug effects | Neoplasms - immunology | Protein Kinase Inhibitors - therapeutic use | Organ Transplantation - adverse effects | Immunosuppressive Agents - adverse effects | Graft Rejection - immunology | Immunocompromised Host | Graft Survival - drug effects | Prevention | Transplantation of organs, tissues, etc | Physiological aspects | Enzyme inhibitors | Carcinogenesis | Patient outcomes | Index Medicus
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2013, Volume 132, Issue 6, pp. 1429 - 1438
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 4/2010, Volume 50, Issue 8, pp. 1101 - 1111
Journal Article
Journal Article